News About: Pharm. Industry
Anti-impotence drug sets off war among competitors
Competition is about to heat up in the domestic anti-impotence drug market, as Bayer Korea and Chong Kung Dang Pharmaceutical, like the successful strategic alliance of Lilly Korea and Daewoong Pharm, finally agreed t...
Handok launches Tracleer in pulmonary arterial hypertensionHandok Pharm announced on November 1 that Tracleer tablet (bosentan) is now available upon prescription to all patients in Korea.
In March of this year, the Korea Food and Dr...
|
Kang Han-goo named head of Bayer Schering Pharma in TaiwanBayer HealthCare AG, a subsidiary of Bayer AG in Germany, has recently named Kang Han-goo, executive managing director at Bayer Korea, as the new president of Bayer Schering Pha...
|
Domestic pharmaceutical firms will likely lose momentum under proposed quantity-price linkage system
The government's plan to introduce a system of linking the quantity and quantity of drugs in evaluating drugs to be covered by national insurance will result in discouraging local pharmaceutical firms' will to develop...
KFDA granted sale of Symbicort Smart.
AstraZeneca Korea has received a KFDA approval for the sales of Symbicort (budesonide/formoterol), a combination of an inhaled corticosteroid and long-acting bronchodilator, for the treatment of asthma and Chronic Obs...
Drug industry unlikely to achieve their sales forecast.
Most of local pharmaceutical companies seem hardly to achieve their sales target this year mainly because of the KFDA's delayed approval for the applications of new products stemming from the bio equivalency scandals ...
Choong-wae Pharm launches new diabetic agent Glufast tab.Choonwae-Pharm said it has recently launched a new product Glufast tablet (mitiglinide) for the treatment of type II diabetes.
Glufast is an insulin secretagogue with a rapid...
|
Samjin appointed as one of 200 Best Asian industries.
Forbes Asia, a famous American economic journal, reported that 5 local small and medium sized drug companies including Hanmi, Samjin, Bukwang, Whanin and Yuyu were nominated as one of the 200 Best Under a Billion.
...
A foreign adviser: Local industry to seek overseas OTC markets
Mr. Nicholas Hall recently visited to Korea by an invitation of Zuellig Korea. He is an international OTC drug market expert and runs a consultation company named "Nicholas Hall & Co". During his visit to Korea, a pre...
Daewoong Pharm seeks bigger market share of NaramigDaewoong Pharm plans to expand its share of Naramig tablets (naratriptan) as one of the leading items in the local anti-migraine drug market.
Naratriptan is a triptan drug de...
|
